· 6/23/2004
Xechem, Inc., and Xechem International, Inc. v. Bristol-Myers Squibb Company
Citations
- 372 F.3d 899
- 71 U.S.P.Q. 2d (BNA) 1220
- 2004 U.S. App. LEXIS 12424
- 2004 WL 1396243
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- holding that a plaintiff pleads himself out of court when his complaint includes all the necessary ingredients of an impenetrable defense
- finding that an action taken to extend the five-year exclusivity period for -marketing a pharmaceutical was sufficient to restart the statute of limitations
- reversing dismissal of complaint and declining to affirm dismissal on the alternative ground that plaintiff had not shown injury even when it had not yet filed an ANDA
- “Only when the plaintiff pleads itself out of court--that is, admits all the ingredients of an impenetrable defense--may a complaint that otherwise states a claim be dismissed under Rule 12(b)(6).”
- “Complaints need not contain any information about defenses and may not be dismissed for that omission.”
- failure to “plead around” a likely affirmative defense is typically not a proper basis for dismissal
Source: CourtListener parenthetical corpus (CC0).
Judges: Diane, Easterbrook, Kanne, Wood
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.